February 26, 2024 · Form 4 insider transaction
Ambrose Kristen sold 883 shares of Vertex Pharmaceuticals Incorporated at $425.70 per share, a transaction worth $375.9K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 1 day after the transaction.
Transaction made pursuant to Ms. Ambrose's company approved trading plan under Rule 10b5-1, which was entered into on 02/28/2023.